ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,534,000 | +211.2% | 16,502 | +99.3% | 0.01% | +50.0% |
| Q3 2021 | $493,000 | -18.5% | 8,282 | -6.7% | 0.00% | -20.0% |
| Q2 2021 | $605,000 | +74.9% | 8,873 | +78.1% | 0.01% | -61.5% |
| Q1 2021 | $346,000 | -16.0% | 4,982 | -7.1% | 0.01% | -18.8% |
| Q4 2020 | $412,000 | +3.0% | 5,364 | +0.2% | 0.02% | -5.9% |
| Q3 2020 | $400,000 | +22.3% | 5,351 | +3.0% | 0.02% | +13.3% |
| Q2 2020 | $327,000 | -11.4% | 5,197 | -40.8% | 0.02% | +66.7% |
| Q1 2020 | $369,000 | -10.2% | 8,783 | -3.0% | 0.01% | +12.5% |
| Q4 2019 | $411,000 | +5.4% | 9,058 | +6.3% | 0.01% | 0.0% |
| Q3 2019 | $390,000 | -22.9% | 8,524 | -1.3% | 0.01% | -33.3% |
| Q2 2019 | $506,000 | +52.4% | 8,635 | +16.6% | 0.01% | +50.0% |
| Q1 2019 | $332,000 | +19.9% | 7,406 | +4.1% | 0.01% | 0.0% |
| Q4 2018 | $277,000 | -14.2% | 7,114 | -3.9% | 0.01% | 0.0% |
| Q2 2018 | $323,000 | +43.6% | 7,406 | +30.1% | 0.01% | +33.3% |
| Q1 2018 | $225,000 | – | 5,694 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 4,190,000 | $321,918,000 | 5.54% |
| Prosight Management, LP | 145,700 | $11,194,000 | 5.17% |
| Integral Health Asset Management, LLC | 200,000 | $15,366,000 | 4.57% |
| Copernicus Capital Management, LLC | 3,740 | $287,000 | 4.47% |
| GREAT POINT PARTNERS LLC | 345,120 | $26,516,000 | 4.31% |
| Asymmetry Capital Management, L.P. | 101,245 | $7,779,000 | 3.55% |
| First Light Asset Management, LLC | 321,967 | $24,737,000 | 1.83% |
| DAFNA Capital Management LLC | 76,815 | $5,902,000 | 1.76% |
| SECTORAL ASSET MANAGEMENT INC | 320,059 | $24,590,000 | 1.73% |
| Nicholas Investment Partners, LP | 276,633 | $21,254,000 | 1.64% |